A Novel Therapeutic Approach to Treat Chronic Pelvic Pain
CompletedNot applicableNCT05467241
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
To collect pilot data and assess the feasibility of a trial employing a single-arm intervention to study the effects of combined self-induced therapeutic tremors plus mindfulness on symptoms of chronic pelvic pain among women diagnosed with chronic pelvic pain.
Study details
- Official title
- A Pilot Study to Assess the Feasibility of a Randomized Control Trial Employing a Single-arm Intervention, at a Single Institution, to Study the Effects of Combined Self-induced Therapeutic Tremors Plus Mindfulness on Symptoms of Chronic Pelvic Pain.
- Conditions
- Interventions
- Behavioral: Self-induced therapeutic tremor (SITT) combined with mindfulness
- Sponsor
- University of Tennessee Graduate School of Medicine
- Start date
- 2021-08-12
- Primary completion
- 2022-04-29
- Sex
- Female
- Age range
- from 18 Years to 80 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Women * Age \>18 * Physical requirements: be able to complete the intervention sessions * Not seeking other therapeutic modalities, such as acupuncture, PT, during study duration * Free from surgery for \>3 months * being treated clinically for chronic pelvic pain and related conditions * CPP of 6 months or more (to be considered chronic) * Availability to commit to the 4-week intervention (two 60-minute sessions per week at a specified time, for 4 weeks) * Internet access and consistent access to phone/email/text communication Exclusion Criteria: * Pregnancy * Illicit substance use (e.g. cocaine, methamphetamines, heroin, street drugs) - marijuana and CBD oil and related supplements will be considered on a case-by-case basis by the principal investigators * Current psychiatric illness/social situation that would limit compliance with study requirements, as determined by the principal investigators
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05467241